See the DrugPatentWatch profile for Austedo
The cost of Austedo XR (deutetrabenazine) can vary significantly based on factors such as insurance coverage, pharmacy, and dosage. The list price for Austedo XR can be substantial, with some sources indicating costs upwards of $3,000 to $7,000 or more for a one-month supply [1].
How do patients access Austedo XR at a lower cost?
Patients may be able to reduce out-of-pocket expenses through patient assistance programs offered by the manufacturer, or by utilizing coupons and discount cards. Medicare and other insurance plans may also offer coverage, but patient co-pays can still be considerable without additional assistance [1].
What is Austedo XR used for?
Austedo XR is a prescription medication used to treat chorea associated with Huntington's disease and tardive dyskinesia [2]. Chorea is characterized by involuntary, irregular, and often jerky movements, while tardive dyskinesia is a side effect of certain medications that causes involuntary movements, most commonly in the face [2].
How does Austedo XR work?
Austedo XR contains deutetrabenazine, which is thought to work by affecting certain chemicals in the brain. It reduces the levels of monoamines like dopamine, which are believed to contribute to the involuntary movements seen in Huntington's disease and tardive dyskinesia [3].
When does the patent for Austedo XR expire?
The patent landscape for Austedo XR is complex, involving multiple patents covering the drug and its uses. Information on specific patent expiry dates can be found through resources that track pharmaceutical patents [4]. DrugPatentWatch.com provides detailed information on drug patents and their expiry timelines [4].